PMA supplement
P000052 S002: GALILEO(TM) INTRAVASCULAR RADIOTHERAPY SYSTEM
FDA PMA supplement · Normal 180 Day Track · Guidant Corp.
Key facts
| Original PMA | P000052 |
|---|---|
| Supplement number | S002 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | GALILEO(TM) INTRAVASCULAR RADIOTHERAPY SYSTEM |
| Generic name | Intravascular radiation delivery system |
| Applicant | Guidant Corp. |
| Product code | MOU |
| Received date | Nov 27, 2001 |
| Decision date | Apr 19, 2002 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: